Effects of Napping in Sleep-Restricted Adolescents
Effectiveness of a Daytime Nap on Alleviating Cognitive Impairment Due to Short Sleep in Adolescents
1 other identifier
interventional
57
1 country
1
Brief Summary
To examine the neurobehavioural responses to two successive cycles of sleep restriction and recovery in adolescents, and to determine the benefits of napping on cognitive performance, alertness, and mood. 57 participants, aged 15 to 19 years old, were divided into nap and no-nap groups. Both groups underwent two cycles of sleep restriction and recovery over 15 days. The nap group received an afternoon sleep opportunity lasting 1 hour.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 15, 2016
CompletedFirst Posted
Study publicly available on registry
July 20, 2016
CompletedJuly 20, 2016
July 1, 2016
4 months
June 15, 2016
July 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change in sustained attention assessed with the Psychomotor Vigilance Task from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Number of attention lapses (\>500ms)
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in working memory assessed with the 1-back task from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Number of correct responses in the 1-back task
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in executive functions assessed with the 3-back task from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Number of correct responses in the 3-back task
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in the level of subjective sleepiness assessed with the Karolinska Sleepiness Scale from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Score on the Karolinska Sleepiness Scale (1-9 points)
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in positive mood assessed with the Positive and Negative Affect Scale (PANAS) from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Total score on the positive subscale of the PANAS
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in negative mood assessed with the Positive and Negative Affect Scale (PANAS) from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Total score on the negative subscale of the PANAS
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in speed of processing assessed with the Mental Arithmetic Task from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Number of correct responses in the task
3 times daily (10:00, 15:45, and 20:00) for 15 days
Change in speed of processing assessed with the Symbol Digit Modalities Task from morning to afternoon and then evening from baseline days to the first and second cycles of sleep restriction and recovery
Number of correct responses in the task
3 times daily (10:00, 15:45, and 20:00) for 15 days
Secondary Outcomes (10)
Change in total sleep duration at night assessed with polysomnography from baseline nights to the first and second cycles of sleep restriction and recovery
Nocturnal sleep on nights 1 & 3 (baseline), 4, 6 & 8 (first sleep restriction period), 9 (first recovery period), 11 & 13 (second sleep restriction period), & 14 (second recovery period)
Change in N1 sleep duration at night assessed with polysomnography from baseline nights to the first and second cycles of sleep restriction and recovery
Nocturnal sleep on nights 1 & 3 (baseline), 4, 6 & 8 (first sleep restriction period), 9 (first recovery period), 11 & 13 (second sleep restriction period), & 14 (second recovery period)
Change in N2 sleep duration at night assessed with polysomnography from baseline nights to the first and second cycles of sleep restriction and recovery
Nocturnal sleep on nights 1 & 3 (baseline), 4, 6 & 8 (first sleep restriction period), 9 (first recovery period), 11 & 13 (second sleep restriction period), & 14 (second recovery period)
Change in N3 sleep duration at night assessed with polysomnography from baseline nights to the first and second cycles of sleep restriction and recovery
Nocturnal sleep on nights 1 & 3 (baseline), 4, 6 & 8 (first sleep restriction period), 9 (first recovery period), 11 & 13 (second sleep restriction period), & 14 (second recovery period)
Change in REM sleep duration at night assessed with polysomnography from baseline nights to the first and second cycles of sleep restriction and recovery
Nocturnal sleep on nights 1 & 3 (baseline), 4, 6 & 8 (first sleep restriction period), 9 (first recovery period), 11 & 13 (second sleep restriction period), & 14 (second recovery period)
- +5 more secondary outcomes
Study Arms (2)
No nap
NO INTERVENTIONAfter each night with a 5-hour sleep opportunity, participants did not have a daytime nap opportunity, but instead watched documentaries.
Nap
EXPERIMENTALAfter each night with a 5-hour sleep opportunity, participants had the chance to take a daytime nap from 14:00 to 15:00.
Interventions
Eligibility Criteria
You may qualify if:
- healthy
- no sleep disorder
- body mass index not greater than 30
You may not qualify if:
- smoker
- habitual short sleeper (time in bed during term time of less than 6 hours and no sign of sleep extension of greater than 1 hour on weekends)
- consumption of more than 5 cups of caffeinated beverages a day
- travelling across more than 2 time zones in the month prior to the study protocol
- diagnosed with any psychiatric conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Duke-NUS Medical School
Singapore, Singapore, 169857, Singapore
Related Publications (2)
Lo JC, Ang JWA, Koa TB, Ong JL, Lim J. Predicting vigilance vulnerability during 1 and 2 weeks of sleep restriction with baseline performance metrics. Sleep Adv. 2022 Oct 25;3(1):zpac040. doi: 10.1093/sleepadvances/zpac040. eCollection 2022.
PMID: 37193393DERIVEDLo JC, Koa TB, Ong JL, Gooley JJ, Chee MWL. Staying vigilant during recurrent sleep restriction: dose-response effects of time-in-bed and benefits of daytime napping. Sleep. 2022 Apr 11;45(4):zsac023. doi: 10.1093/sleep/zsac023.
PMID: 35089345DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael WL Chee, MBBS
Duke-NUS Graduate Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Neuroscience and Behavioural Disorders Program; Director, Centre for Cognitive Neuroscience
Study Record Dates
First Submitted
June 15, 2016
First Posted
July 20, 2016
Study Start
August 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
July 20, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share